Solid Biosciences Inc. Gains 68.42%
Solid Biosciences Inc. (SLDB:NASDAQ) soared at $5.76, representing a gain of 68.4%. On Thu, Dec 07, 2023, SLDB:NASDAQ touched a New 2-Week High of $5.76. The stock got featured on our News Catalysts scanner on Thu, Dec 07, 2023 at 09:35 AM in the 'BIOTECH' category. From Fri, Nov 24, 2023, the stock recorded 66.67% Up Days and 70.00% Green Days
About Solid Biosciences Inc. (SLDB:NASDAQ)
Solid Biosciences Inc is a life science company engaged in developing therapies for Duchenne muscular dystrophy. Its product candidate, SGT-001, is a gene transfer under development to restore functional dystrophin protein expression in patients' muscles.
Top 10 Gainers:
- Tempo Automation Holdings Inc. (TMPO:NASDAQ), 350%
- Signature Bank (SBNY:NASDAQ), 77.78%
- Solid Biosciences Inc. (SLDB:NASDAQ), 68.42%
- Cyngn Inc. (CYN:NASDAQ), 64%
- Altisource Asset Management Corporation (AAMC:NYSEMKT), 54.6%
- Satellogic Inc. (SATL:NASDAQ), 45.63%
- Hempacco Co. Inc. (HPCO:NASDAQ), 44.17%
- Fitell Corporation (FTEL:NASDAQ), 42.25%
- Save Foods Inc. (SVFD:NASDAQ), 41.86%
- China Liberal Education Holdings Limited (CLEU:NASDAQ), 38.68%